Abraham has over 17 years of experience in biopharmaceutical commercialization and leadership. Prior to Tiburio, he served as COO at scPharmaceuticals. He was integral in raising over $140 million as well as closing the company’s IPO. Previously, he served in vice presidential roles at Keryx Biopharmaceuticals and Ironwood Pharmaceuticals. Abraham held several positions at Genzyme/Sanofi, ultimately as the Director, Renal Global Marketing, through which he led the launch of Renvela® and held marketing responsibility for the company’s renal franchise.
.svg)
